How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Peripheral Imaging Catheter Market
- By Imaging Technology: Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Near-Infrared Spectroscopy (NIRS), Photoacoustic Imaging
- By Catheter Design: Monorail Catheters, Rapid Exchange Catheters, Over-the-Wire Catheters
- By Application Area: Peripheral Artery Disease (PAD) Imaging, Coronary Artery Imaging, Neurovascular Imaging, Renal Artery Imaging
- By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics
- By Procedure Type: Diagnostic Imaging Procedures, Interventional Imaging Procedures
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Optical Coherence Tomography (OCT) leads By Imaging Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Peripheral Imaging Catheter Market report
A complete, evidence-based study - 12 chapters and 119 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Imaging Technology 4
Catheter Design 3
Application Area 4
End-User 3
Procedure Type 2
Companies profiled
Boston Scientific Corporation
Terumo Corporation
Philips Healthcare
Siemens Healthineers
Abbott Laboratories
Medtronic plc
Canon Medical Systems Corporation
GE Healthcare
Asahi Intecc Co. Ltd.
Cook Medical
Cardinal Health
Bard Peripheral Vascular (BD)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Canon Medical Systems Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →GE Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Asahi Intecc Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Cook Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cardinal Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Bard Peripheral Vascular (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Teleflex Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Vascular Solutions Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Inari Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,025M by 2033 · 11.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Optical Coherence Tomography (OCT)48.0
- Intravascular Ultrasound (IVUS)24.0
- Near-Infrared Spectroscopy (NIRS)16.0
- Photoacoustic Imaging12.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$712.1M → $1,813M · 12.4%
Europe$496.3M → $1,179M · 11.4%
Asia Pacific$453.2M → $1,054M · 11.1%
Latin America$280.5M → $719.5M · 12.5%
Middle East and Africa$215.8M → $466.6M · 10.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.102026
11.102027
11.122028
11.132029
11.142030
11.152031
11.162032
11.182033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Boston Scientific Corporation20.0
- Terumo Corporation12.7
- Philips Healthcare8.7
- Siemens Healthineers16.8
- Abbott Laboratories6.9
- Medtronic plc7.0
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Imaging Technology13.1%
Catheter Design32.3%
Application Area24.4%
End-User18.2%
Procedure Type12.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.7
- Europe22.5
- Asia Pacific20.1
- Latin America13.8
- Middle East and Africa8.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 82 | 98 | 95 | 83 | 76 | 92 | 88 |
| Terumo Corporation | 73 | 70 | 91 | 93 | 73 | 70 | 78 |
| Philips Healthcare | 85 | 83 | 73 | 74 | 86 | 75 | 79 |
| Siemens Healthineers | 74 | 62 | 77 | 78 | 68 | 82 | 74 |
| Abbott Laboratories | 72 | 58 | 56 | 75 | 72 | 61 | 66 |
| Medtronic plc | 60 | 49 | 67 | 62 | 60 | 49 | 58 |
| Canon Medical Systems Corporation | 55 | 53 | 64 | 61 | 58 | 53 | 57 |
| GE Healthcare | 35 | 58 | 51 | 39 | 55 | 52 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Boston Scientific Corporation
- Terumo Corporation
- Philips Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Terumo Corporation | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Philips Healthcare | ◐ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Siemens Healthineers | ◐ | ◐ | ✓ | ◐ | − | ✓ |
| Abbott Laboratories | ✓ | ◐ | ◐ | ◐ | ◐ | − |
| Medtronic plc | ◐ | ◐ | ◐ | − | − | − |
| Canon Medical Systems Corporation | ◐ | − | ✓ | ◐ | ◐ | − |
| GE Healthcare | − | ◐ | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Boston Scientific Corporation88
2Philips Healthcare79
3Terumo Corporation78
4Siemens Healthineers74
5Abbott Laboratories66
6Medtronic plc58
7Canon Medical Systems Corporation57
8GE Healthcare48
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Boston Scientific CorporationTerumo CorporationPhilips Healthcare
Challenger1
Strong scale, closing on the leaders.
Siemens Healthineers
Contender3
Focused players with pockets of strength.
Abbott LaboratoriesMedtronic plcCanon Medical Systems Corporation
Niche1
Specialists in a single segment or region.
GE Healthcare
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Imaging Technology in North America, then scale across Peripheral Imaging Catheter Market — a $159M beachhead inside a $2.80B market.
Beachhead (SOM)$159Mobtainable near-term
Serviceable (SAM)$1.06Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Optical Coherence Tomography (OCT)
Best fit — highest urgency & budget in Imaging Technology.
Economic buyer79 fit
Intravascular Ultrasound (IVUS)
Strong fit — clear ROI and a fast path to value.
End user67 fit
Near-Infrared Spectroscopy (NIRS)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Imaging Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Catheter Design & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application Area
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel32%
Digital / self-serve18%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Imaging Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Peripheral Imaging Catheter Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation12%
Closed-won6%
$9.7KCAC
$37KLTV
3.8:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Peripheral Imaging Catheter Market is a resilient opportunity — $8.15B by 2033, compounding at 5.7%.
TAM · 2025$5.21Btoday
TAM · 2033$8.15Bforecast
CAGR5.7%2027–2033
Cumulative$59.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.15BTotal addressable market
SAM$2.79BServiceable available market
SOM$450MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.7% CAGR
Demand compounds through 2033, outpacing GDP across Imaging Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Imaging Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.15BLarge & growingTAM by 2033 at 5.7% CAGR
$2.79BServiceable nowreachable with today’s model
$450MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.36BBear3.7% CAGR
$8.15BBase5.7% CAGR
$10.4BBull7.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Catheter Design optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Peripheral Imaging Catheter Market — a $8.24B market by 2033. Plan: grow share from 7.9% to 15.6%.
Market size · 2033$8.24Btotal addressable
Market CAGR6.7%2027–2033
Target share15.6%from 7.9% today
Revenue ambition$1.29Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 15.6% | Behind |
| Revenue | $650M | $1.29B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 33.3% | 40.0% | On track |
| Customer retention | 90.6% | 93.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Imaging Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Catheter Design capability
A defensible second engine — invest in Catheter Design to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Imaging Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Catheter Design
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $135M capacity & capability investment
- Greenlight bolt-on M&A in Catheter Design
- Authorise North America expansion plan
- Fund R&D program for Imaging Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Peripheral Imaging Catheter Market conversation — a $4.88B market you can size, segment and defend in minutes.
Market size · 2033$4.88Btotal opportunity
Growth7.6%CAGR to 2033
Addressable buyers1,022+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Imaging Technology
Goal Grow share in Imaging Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 2 mopayback period
$66K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Boston Scientific CorporationTerumo CorporationPhilips HealthcareSiemens HealthineersAbbott LaboratoriesMedtronic plcCanon Medical Systems CorporationGE Healthcare+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Peripheral Imaging Catheter Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Peripheral Imaging Catheter Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Peripheral Guide Wires Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportPeripheral Embolization Devices Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportPeripheral Drug-eluting Balloon Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportPeripheral Drug-Coated Balloon Market
Market size, share, segmentation and regional forecast.
$363M market · 2025 base year
View reportPeripheral Circulatory Disease Medications Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportPeripheral Chronic Total Occlusion Device Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportPeripheral Catheterization Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportPeripheral Blood Mononuclear Cells (PBMC) Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportPeripheral Balloon Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportPeripheral Balloon Dilation Catheter Market
Market size, share, segmentation and regional forecast.
$600M market · 2025 base year
View reportPeripheral Artery Stent Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportPeripheral Artery Revascularisation Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.